<code id='034CC38C8E'></code><style id='034CC38C8E'></style>
    • <acronym id='034CC38C8E'></acronym>
      <center id='034CC38C8E'><center id='034CC38C8E'><tfoot id='034CC38C8E'></tfoot></center><abbr id='034CC38C8E'><dir id='034CC38C8E'><tfoot id='034CC38C8E'></tfoot><noframes id='034CC38C8E'>

    • <optgroup id='034CC38C8E'><strike id='034CC38C8E'><sup id='034CC38C8E'></sup></strike><code id='034CC38C8E'></code></optgroup>
        1. <b id='034CC38C8E'><label id='034CC38C8E'><select id='034CC38C8E'><dt id='034CC38C8E'><span id='034CC38C8E'></span></dt></select></label></b><u id='034CC38C8E'></u>
          <i id='034CC38C8E'><strike id='034CC38C8E'><tt id='034CC38C8E'><pre id='034CC38C8E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:653
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Emergent cuts jobs, executive role in business shake
          Emergent cuts jobs, executive role in business shake

          SpencerPlatt/GettyImagesEmergentBioSolutions,themanufacturingcompanythatfellintohotwaterin2021duetoa

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Eli Lilly reports tirzepatide MASH success during Q4 earnings

          DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver